Oltea Sampetrean
- Genetics top 5%
- Glioma Diagnosis and Treatment 21
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 5
- Oncology top 10%
- Cancer Cells and Metastasis 8
-
- Mitochondrial Function and Pathology 3
-
- Cellular Mechanics and Interactions 3
-
- 3D Printing in Biomedical Research 5
- Nanoplatforms for cancer theranostics 3
-
- Intracranial Aneurysms: Treatment and Complications 3
- Co-authors
- Hideyuki SayaKazunari YoshidaEiji SugiharaSatoru OsukaNobuyuki OnishiNoriaki MinamiYoshimi ArimaSatoshi Fujita
- Cited by
- GeneticsCancer ResearchOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Oltea Sampetrean
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Genetics 320
- Cancer Research 307
- Oncology 296
- Molecular Biology 570
- Cell Biology 107
Countries citing papers authored by Oltea Sampetrean
This map shows the geographic impact of Oltea Sampetrean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oltea Sampetrean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oltea Sampetrean more than expected).
Fields of papers citing papers by Oltea Sampetrean
This network shows the impact of papers produced by Oltea Sampetrean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oltea Sampetrean. The network helps show where Oltea Sampetrean may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oltea Sampetrean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 63 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 35 | |
| 12 | 2020 | 21 | |
| 13 | 2018 | 26 | |
| 14 | 2017 | 29 | |
| 15 | 2017 | 17 | |
| 16 | 2017 | 25 | |
| 17 | The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model | 2016 | 0 |
| 18 | 2011 | 75 | |
| 19 | 2009 | 45 | |
| 20 | 2006 | 14 |
About Oltea Sampetrean
Oltea Sampetrean is a scholar working on Genetics, Cancer Research and Developmental Neuroscience, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (21 papers), Cancer Cells and Metastasis (8 papers), 3D Printing in Biomedical Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Mitochondrial Function and Pathology (3 papers), Cellular Mechanics and Interactions (3 papers), Intracranial Aneurysms: Treatment and Complications (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Genetics (320 citations), Cancer Research (307 citations) and Oncology (296 citations). Oltea Sampetrean has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Hideyuki Saya, Kazunari Yoshida, Eiji Sugihara, Satoru Osuka, Nobuyuki Onishi, Noriaki Minami, Yoshimi Arima, Satoshi Fujita, Ryo Sudo and Naoyoshi Koike. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.